Cargando…

Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome

BACKGROUND: Mycophenolate mofetil (MMF) has emerged as a new agent for treatment of a variety of glomerular diseases. This study examines the safety and efficacy of MMF in treating pediatric patients with steroid-dependent (SD) and/or frequently relapsing (FR) nephrotic syndrome (NS). METHODS: We re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Akash, Samhar, Al Makdama, Abdulkarim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	King Faisal Specialist Hospital and Research Centre 2005
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089728/ https://www.ncbi.nlm.nih.gov/pubmed/16270759 http://dx.doi.org/10.5144/0256-4947.2005.380

Ejemplares similares

Mycophenolate Mofetil in the Treatment of Steroid-Dependent or Frequently Relapsing Nephrotic Syndrome in Children: A Meta-Analysis
por: Xiang, Xin, et al.
Publicado: (2021)

Efficacy of mycophenolate treatment in adults with steroid-dependent/frequently relapsing idiopathic nephrotic syndrome
por: Sandoval, Diego, et al.
Publicado: (2017)

Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children
por: Kang, Zhijuan, et al.
Publicado: (2015)

Safety of percutaneous renal biopsy as an outpatient procedure in pediatric patients
por: Al Makdama, Abdulkarim, et al.
Publicado: (2006)

The safety and efficacy of mycophenolate mofetil in children and adolescents with steroid-dependent nephrotic syndrome: a single-centre study
por: Karunamoorthy, Saravanakumar, et al.
Publicado: (2019)

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome
por: Dorresteijn, Eiske M., et al.
Publicado: (2008)

Randomised controlled trial comparing rituximab to mycophenolate mofetil in children and young adults with steroid-dependent idiopathic nephrotic syndrome: study protocol
por: Lugani, Francesca, et al.
Publicado: (2021)

Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)
por: Horinouchi, Tomoko, et al.
Publicado: (2018)

Efficacy of Levamisole in children with Frequent Relapsing and Steroid Dependent Nephrotic Syndrome at Tertiary Care Center-Karachi
por: Moorani, Khemchand N, et al.
Publicado: (2020)

Immunophenotypic Alterations in Adult Patients with Steroid-Dependent and Frequently Relapsing Nephrotic Syndrome
por: Casiraghi, Federica, et al.
Publicado: (2023)

Systematic Review and Meta-Analysis of Rituximab for Steroid-Dependent or Frequently Relapsing Nephrotic Syndrome in Children
por: Gao, Xia, et al.
Publicado: (2021)

A single-centre retrospective study of the safety and efficacy of mycophenolate mofetil in children and adolescents with nephrotic syndrome
por: Hassan, Akhila V., et al.
Publicado: (2013)

Efficacy of Mycophenolate Mofetil as a Remission Maintaining Agent in Idiopathic Childhood Nephrotic Syndrome
por: Nandi, M., et al.
Publicado: (2019)

Continuous B-cell depletion in frequently relapsing, steroid-dependent and steroid-resistant nephrotic syndrome
por: Cortazar, Frank B, et al.
Publicado: (2018)

Experience with second line drugs in frequently relapsing and steroid dependent childhood nephrotic syndrome in a large Saudi center
por: Alsaran, Khalid, et al.
Publicado: (2017)

Immunosuppressive therapy in children with steroid-resistant, frequently-relapsing, and steroid-dependent idiopathic nephrotic syndrome: a single center experience
por: Moustafa, Bahia Hassan, et al.
Publicado: (2016)

Levamisole therapy in children with frequently relapsing and steroid-dependent nephrotic syndrome: a single-center experience
por: Kuźma-Mroczkowska, Elżbieta, et al.
Publicado: (2016)

Population Pharmacokinetics of Rituximab in Pediatric Patients With Frequent-Relapsing or Steroid-Dependent Nephrotic Syndrome
por: Chen, Yewei, et al.
Publicado: (2021)

Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome
por: Basu, Biswanath, et al.
Publicado: (2020)

Cost-Effectiveness of Administering Rituximab for Steroid-Dependent Nephrotic Syndrome and Frequently Relapsing Nephrotic Syndrome: A Preliminary Study in Japan
por: Takura, Tomoyuki, et al.
Publicado: (2017)

Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil versus prednisone: protocol for a randomised, controlled, multicentre trial (INTENT study)
por: Ehren, Rasmus, et al.
Publicado: (2018)

Severe Relapsing Goodpasture's Disease Successfully Treated with Mycophenolate Mofetil
por: Malho, Anabela, et al.
Publicado: (2010)

Mycophenolate mofetil/sirolimus/steroids: COVID-19 pneumonia: case report
Publicado: (2021)

Ciclosporin/mycophenolate-mofetil/steroids: COVID-19 pneumonia: case report
Publicado: (2021)

Use of mycophenolate mofetil in patients with pediatric and adult primary nephrotic syndrome: information from a Japanese hospital claims database
por: Funatogawa, Takashi, et al.
Publicado: (2022)

Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders
por: Sheikhzadeh, Sanaz, et al.
Publicado: (2013)

The Application of Inosine 5′-Monophosphate Dehydrogenase Activity Determination in Peripheral Blood Mononuclear Cells for Monitoring Mycophenolate Mofetil Therapy in Children with Nephrotic Syndrome
por: Sobiak, Joanna, et al.
Publicado: (2020)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Rituximab, Mycophenolic Acid, and Calcineurin Inhibitors Achieve Long-Term Remission in Pediatric Focal Segmental Glomerulosclerosis with Steroid-Resistant and Frequently Relapsing Nephrotic Syndrome: A Report of Two Cases
por: Ambarsari, Cahyani Gita, et al.
Publicado: (2022)

Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)

Severe Enteropathy From Mycophenolate Mofetil
por: Jehangir, Asad, et al.
Publicado: (2016)

Autoimmune Gastritis Treated With Mycophenolate Mofetil
por: Harb, Ali H., et al.
Publicado: (2020)

Mycophenolate mofetil: Cytopenia: case report
Publicado: (2021)

Mycophenolate mofetil in giant cell arteritis
por: Pankow, Anne, et al.
Publicado: (2023)

Prediction of steroid resistance and steroid dependence in nephrotic syndrome children
por: Zaorska, Katarzyna, et al.
Publicado: (2021)

Mycophenolate-mofetil/mycophenolic-acid: COVID-19: 4 case reports
Publicado: (2021)

Long-term Treatment Outcome of Tubulo-interstitial Nephritis and Uveitis Syndrome Associated Panuveitis with Steroid and Mycophenolate Mofetil
por: Leung, Kai Ching Peter, et al.
Publicado: (2020)

Use of mycophenolate mofetil (MMF) in lupus nephritis (LN) in children
por: Indaco, R, et al.
Publicado: (2008)

Efficacy and tolerability of mycophenolate mofetil in a pediatric Rasmussen syndrome()
por: Orsini, A., et al.
Publicado: (2019)

Genetic analysis and outcomes of Omani children with steroid‐resistant nephrotic syndrome
por: Al Riyami, Mohamed S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3td6u4oo1tujgoutf72nl2lam8